Activation of Free Fatty Acid Receptor 4 (FFA4) Ameliorates Ovalbumin-Induced Allergic Asthma by Suppressing Activation of Dendritic and Mast Cells in Mice

被引:17
|
作者
Son, So-Eun [1 ]
Koh, Jung-Min [2 ]
Im, Dong-Soon [1 ,3 ]
机构
[1] Kyung Hee Univ, Grad Sch, Dept Biomed & Pharmaceut Sci, Seoul 02447, South Korea
[2] Univ Ulsan, Div Endocrinol & Metab, Asan Med Ctr, Coll Med, Seoul 05505, South Korea
[3] Kyung Hee Univ, Grad Sch, Dept Basic Pharmaceut Sci, Seoul 02447, South Korea
基金
新加坡国家研究基金会;
关键词
allergy; asthma; free fatty acid receptor 4; FFA4; omega-3 polyunsaturated fatty acids; DAMPENS AIRWAY INFLAMMATION; DIETARY SUPPLEMENTATION; INSULIN-RESISTANCE; RESOLVIN E1; GPR120; OMEGA-3-FATTY-ACIDS; RESOLUTION; LIPIDS; MODEL;
D O I
10.3390/ijms23095270
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Epidemiological and clinical studies have suggested that intake of n-3 polyunsaturated fatty acids (PUFA) reduces the incidence of allergic airway diseases and improves pulmonary function in patients with allergic asthma. However, the pharmacological targets of PUFA have not been elucidated upon. We investigated whether free fatty acid receptor 4 (FFA4, also known as GPR120) is a molecular target for beneficial PUFA in asthma therapy. In an ovalbumin (OVA)-induced allergic asthma model, compound A (a selective agonist of FFA4) was administrated before OVA sensitization or OVA challenge in FFA4 wild-type (WT) and knock-out (KO) mice. Compound A treatment of RBL-2H3 cells suppressed mast cell degranulation in vitro in a concentration-dependent manner. Administration of compound A suppressed in vivo allergic characteristics in bronchoalveolar lavage fluid (BALF) and lungs, such as inflammatory cytokine levels and eosinophil accumulation in BALF, inflammation and mucin secretion in the lungs. Compound A-induced suppression was not only observed in mice treated with compound A before OVA challenge, but in mice treated before OVA sensitization as well, implying that compound A acts on mast cells as well as dendritic cells. Furthermore, this suppression by compound A was only observed in FFA4-WT mice and was absent in FFA4-KO mice, implying that compound A action is mediated through FFA4. Activation of FFA4 may be a therapeutic target of PUFA in allergic asthma by suppressing the activation of dendritic cells and mast cells, suggesting that highly potent specific agonists of FFA4 could be a novel therapy for allergic asthma.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Investigating the role of IL-4 receptor alpha signalling through CD4+ T cells in ovalbumin-induced allergic airway disease
    Jayakumar, J.
    Nieuwenhuizen, N.
    Kirstein, F.
    Emedi, B.
    Brombacher, F.
    ALLERGY, 2011, 66 : 441 - 442
  • [42] FoxO4 mediates macrophage M2 polarization by promoting LXA4R expression in an ovalbumin-induced allergic asthma model in mice
    Yu, Tong
    Yu, Yiping
    Ma, Yingyu
    Chen, Guoqing
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2023, 51 (04) : 19 - 30
  • [43] An Amide Alkaloid Isolated from Ephedra sinica Ameliorates OVA-Induced Allergic Asthma by Inhibiting Mast Cell Activation and Dendritic Cell Maturation
    Jia, Jufang
    Zeng, Mengnan
    Zhu, Denghui
    Jiao, Xinmian
    Zhang, Beibei
    Yang, Ruolan
    Feng, Weisheng
    Zheng, Xiaoke
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (21)
  • [44] Vildagliptin inhibits high free fatty acid (FFA)-induced NLRP3 inflammasome activation in endothelial cells
    Qi, Yanyan
    Du, Xianhui
    Yao, Xiangyan
    Zhao, Yuanyuan
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2019, 47 (01) : 1067 - 1074
  • [45] Fermented red ginseng and ginsenoside Rd alleviate ovalbumin-induced allergic rhinitis in mice by suppressing IgE, interleukin-4, and interleukin-5 expression
    Kim, Hye In
    Kim, Jeon-Kyung
    Kim, Jae Young
    Han, Myung Joo
    Kim, Dong-Hyun
    JOURNAL OF GINSENG RESEARCH, 2019, 43 (04) : 635 - 644
  • [46] Ceramide Synthase 2 Null Mice Are Protected from Ovalbumin-Induced Asthma with Higher T Cell Receptor Signal Strength in CD4+T Cells
    Shin, Sun-Hye
    Cho, Kyung-Ah
    Yoon, Hee-Soo
    Kim, So-Yeon
    Kim, Hee-Yeon
    Pewzner-Jung, Yael
    Jung, Sung-Ae
    Park, Woo-Jae
    Futerman, Anthony H.
    Park, Joo-Won
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (05) : 1 - 18
  • [47] Gallic acid attenuates allergic airway inflammation via suppressed interleukin-33 and group 2 innate lymphoid cells in ovalbumin-induced asthma in mice
    Wang, Xinhua
    Zhao, Hongqing
    Ma, Chenhui
    Lv, Lei
    Feng, Jinping
    Han, Shuguang
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2018, 8 (11) : 1284 - 1290
  • [48] Receptor tyrosine kinase activation induces free fatty acid 4 receptor phosphorylation, β-arrestin interaction, and internalization
    Villegas-Comonfort, Socrates
    Guzman-Silva, Alejandro
    Teresa Romero-Avila, M.
    Takei, Yoshinori
    Tsujimoto, Gozoh
    Hirasawa, Akira
    Adolfo Garcia-Sainz, J.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 855 : 267 - 275
  • [49] Free fatty acids and protein kinase C activation induce GPR120 (free fatty acid receptor 4) phosphorylation
    Sanchez-Reyes, Omar B.
    Teresa Romero-Avila, M.
    Castillo-Badillo, Jean A.
    Takei, Yoshinori
    Hirasawa, Akira
    Tsujimoto, Gozoh
    Villalobos-Molina, Rafael
    Adolfo Garcia-Sainz, J.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2014, 723 : 368 - 374
  • [50] The Pharmacology of TUG-891, a Potent and Selective Agonist of the Free Fatty Acid Receptor 4 (FFA4/GPR120), Demonstrates Both Potential Opportunity and Possible Challenges to Therapeutic Agonism
    Hudson, Brian D.
    Shimpukade, Bharat
    Mackenzie, Amanda E.
    Butcher, Adrian J.
    Pediani, John D.
    Christiansen, Elisabeth
    Heathcote, Helen
    Tobin, Andrew B.
    Ulven, Trond
    Milligan, Graeme
    MOLECULAR PHARMACOLOGY, 2013, 84 (05) : 710 - 725